Home › Companies › ANIKA THERAPEUTICS INC. › 2024-2025
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and ANIKA THERAPEUTICS INC.’s Form 8-K, filed June 24, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 20, 2025: 6 items on ANIKA THERAPEUTICS INC.’s Form 8-K, filed June 24, 2025: 2 approved · 4 passed (calculated).
Meeting of July 9, 2024: 5 items on ANIKA THERAPEUTICS INC.’s Form 8-K, filed July 11, 2024: 1 approved · 4 passed (calculated).
Significant dissent: 1 director (20.2% against).
Notable dissent: 1 director (19.6% against); 1 say-on-pay vote (76.8% support); 1 other board item (23.9% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2024-2025 2025-2026
Activist investors: Caligan Partners (13D, 9.9%, as of January 27, 2026)
Explore ANIKA THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are ANIKA THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 24, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX. ANIKA THERAPEUTICS INC. reported 2 meetings in this season; each is tabulated separately below, with its own filing.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Cheryl R. Blanchard, Ph.D. | 8,754,717 | 2,139,215 | 51,074 | -- | 1,406,800 | 80% | Passed (calculated) | — |
| Elect Director: Joseph H. Capper | 10,521,730 | 387,385 | 35,891 | -- | 1,406,800 | 96% | Passed (calculated) | — |
| Elect Director: Glenn R. Larsen, Ph.D. | 8,712,940 | 2,202,441 | 29,625 | -- | 1,406,800 | 80% | Passed (calculated) | — |
| 2. The appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 | 12,076,726 | 248,610 | 26,470 | -- | 0 | 98% | Approved | — |
| 3. Stockholders voted, on a non-binding, advisory basis, to approve the compensation paid to the Company's named executive officers as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables and | 8,374,076 | 2,529,081 | 41,849 | -- | 1,406,800 | 77% | Passed (calculated) | — |
| 4. The Amendment with respect to the 2017 Plan | 8,297,563 | 2,608,925 | 38,518 | -- | 1,406,800 | 76% | Approved | — |
Source: ANIKA THERAPEUTICS INC., Form 8-K, filed with the SEC on June 24, 2025 — read the filing on EDGAR.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Sheryl L. Conley | 10,713,825 | 415,055 | 27,858 | -- | 1,230,326 | 96% | Passed (calculated) | — |
| Elect Director: William R. Jellison | 11,092,818 | 13,085 | 50,835 | -- | 1,230,326 | 99.9% | Passed (calculated) | — |
| Elect Director: Stephen O. Richard | 10,205,467 | 924,213 | 27,058 | -- | 1,230,326 | 92% | Passed (calculated) | — |
| 2. The appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 | 12,337,376 | 43,654 | 6,034 | -- | 0 | 99.6% | Approved | — |
| 3. Stockholders voted, on a non-binding, advisory basis, to approve the compensation paid to the Company's named executive officers as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables and | 11,020,273 | 129,717 | 6,748 | -- | 1,230,326 | 99% | Passed (calculated) | — |
Source: ANIKA THERAPEUTICS INC., Form 8-K, filed with the SEC on July 11, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2024-2025: shareholder support by sector and by company size.
187 asset managers disclosed a vote on at least one ANIKA THERAPEUTICS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Meeting held June 20, 2025.
Combines 3 wordings of this item as funds reported it.
80% Majority: yes · of votes cast
Description as filed by funds: Election of three Class II Directors: Cheryl R. Blanchard, Ph.D.
ANIKA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Cheryl R. Blanchard, Ph.D.”): 8,754,717 for, 2,139,215 against, per its Form 8-K filed June 24, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 80% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 53 asset managers below reported 2,271,764 for, 1,202 against, 828 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 765,129 | 0 | 0 | 0 | For |
| BlackRock | 584,229 | 0 | 0 | 0 | For |
| Fidelity | 311,993 | 0 | 0 | 0 | For |
| Charles Schwab | 136,617 | 0 | 0 | 0 | For |
| MFS | 45,449 | 0 | 0 | 0 | For |
| Equitable | 43,528 | 0 | 0 | 0 | For |
| TIAA | 40,946 | 0 | 0 | 0 | For |
| American Century | 38,649 | 0 | 0 | 0 | For |
| SEI | 29,387 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 24,937 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 22,650 | 0 | 0 | 0 | For |
| Nationwide | 21,802 | 0 | 0 | 0 | For |
| Goldman Sachs | 20,664 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 19,271 | 0 | 0 | 0 | For |
| Thrivent | 15,889 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 14,911 | 0 | 0 | 0 | For |
| Lincoln Financial | 12,381 | 0 | 0 | 0 | For |
| State Street | 10,508 | 0 | 0 | 0 | For |
| Northern Trust | 10,337 | 0 | 0 | 0 | For |
| GuideStone | 9,904 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 8,959 | 0 | 0 | 0 | For |
| Global X | 7,891 | 0 | 0 | 0 | For |
| WisdomTree | 7,612 | 0 | 0 | 0 | For |
| John Hancock | 7,193 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,622 | 0 | 0 | 0 | For |
Showing the 25 largest of 53 asset managers. All 53 are in the interactive database (link above).
Meeting held June 20, 2025.
Combines 3 wordings of this item as funds reported it.
80% Majority: yes · of votes cast
Description as filed by funds: Election of three Class II Directors: Glenn R. Larsen, Ph.D.
ANIKA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Glenn R. Larsen, Ph.D.”): 8,712,940 for, 2,202,441 against, per its Form 8-K filed June 24, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 80% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 53 asset managers below reported 2,251,598 for, 21,368 against, 828 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 765,129 | 0 | 0 | 0 | For |
| BlackRock | 584,229 | 0 | 0 | 0 | For |
| Fidelity | 311,993 | 0 | 0 | 0 | For |
| Charles Schwab | 136,617 | 0 | 0 | 0 | For |
| MFS | 45,449 | 0 | 0 | 0 | For |
| Equitable | 24,278 | 19,250 | 0 | 0 | Mixed |
| TIAA | 40,946 | 0 | 0 | 0 | For |
| American Century | 38,649 | 0 | 0 | 0 | For |
| SEI | 29,387 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 24,937 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 22,650 | 0 | 0 | 0 | For |
| Nationwide | 21,802 | 0 | 0 | 0 | For |
| Goldman Sachs | 20,664 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 19,271 | 0 | 0 | 0 | For |
| Thrivent | 15,889 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 14,911 | 0 | 0 | 0 | For |
| Lincoln Financial | 12,381 | 0 | 0 | 0 | For |
| State Street | 10,508 | 0 | 0 | 0 | For |
| Northern Trust | 10,337 | 0 | 0 | 0 | For |
| GuideStone | 9,904 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 8,959 | 0 | 0 | 0 | For |
| Global X | 7,891 | 0 | 0 | 0 | For |
| WisdomTree | 7,612 | 0 | 0 | 0 | For |
| John Hancock | 7,193 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,622 | 0 | 0 | 0 | For |
Showing the 25 largest of 53 asset managers. All 53 are in the interactive database (link above).
Meeting held June 20, 2025.
Combines 3 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Election of three Class II Directors: Joseph H. Capper
ANIKA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Joseph H. Capper”): 10,521,730 for, 387,385 against, per its Form 8-K filed June 24, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 53 asset managers below reported 2,252,454 for, 20,512 against, 828 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 765,129 | 0 | 0 | 0 | For |
| BlackRock | 584,229 | 0 | 0 | 0 | For |
| Fidelity | 311,993 | 0 | 0 | 0 | For |
| Charles Schwab | 136,617 | 0 | 0 | 0 | For |
| MFS | 45,449 | 0 | 0 | 0 | For |
| Equitable | 24,278 | 19,250 | 0 | 0 | Mixed |
| TIAA | 40,946 | 0 | 0 | 0 | For |
| American Century | 38,649 | 0 | 0 | 0 | For |
| SEI | 29,387 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 24,937 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 22,650 | 0 | 0 | 0 | For |
| Nationwide | 21,802 | 0 | 0 | 0 | For |
| Goldman Sachs | 20,664 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 19,271 | 0 | 0 | 0 | For |
| Thrivent | 15,889 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 14,911 | 0 | 0 | 0 | For |
| Lincoln Financial | 12,381 | 0 | 0 | 0 | For |
| State Street | 10,508 | 0 | 0 | 0 | For |
| Northern Trust | 10,337 | 0 | 0 | 0 | For |
| GuideStone | 9,904 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 8,959 | 0 | 0 | 0 | For |
| Global X | 7,891 | 0 | 0 | 0 | For |
| WisdomTree | 7,612 | 0 | 0 | 0 | For |
| John Hancock | 7,193 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,622 | 0 | 0 | 0 | For |
Showing the 25 largest of 53 asset managers. All 53 are in the interactive database (link above).
Meeting held July 9, 2024.
Combines 4 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
Description as filed by funds: Election of three Class I Directors: Stephen O. Richard
ANIKA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Stephen O. Richard”): 10,205,467 for, 924,213 against, per its Form 8-K filed July 11, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 2,841,556 for, 379,792 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 763,999 | 0 | 0 | 0 | For |
| Dimensional | 642,201 | 0 | 0 | 0 | For |
| BlackRock | 548,753 | 0 | 0 | 0 | For |
| Fidelity | 330,778 | 0 | 0 | 0 | For |
| TIAA | 176,547 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 147,890 | 0 | 0 | Against |
| FRANKLIN VALUE INVESTORS TRUST | 0 | 129,315 | 0 | 0 | Against |
| SEI | 0 | 74,943 | 0 | 0 | Against |
| MFS | 47,551 | 0 | 0 | 0 | For |
| Virtus | 45,579 | 0 | 0 | 0 | For |
| Equitable | 25,343 | 18,800 | 0 | 0 | Mixed |
| QUANTITATIVE MASTER SERIES LLC | 27,284 | 0 | 0 | 0 | For |
| Thrivent | 26,206 | 0 | 0 | 0 | For |
| American Century | 22,730 | 0 | 0 | 0 | For |
| Lincoln Financial | 22,721 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 19,816 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 17,314 | 0 | 0 | 0 | For |
| Goldman Sachs | 11,877 | 0 | 0 | 0 | For |
| Northern Trust | 11,406 | 0 | 0 | 0 | For |
| Voya | 9,353 | 0 | 0 | 0 | For |
| State Street | 8,634 | 1 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 7,508 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 7,451 | 0 | 0 | 0 | For |
| AQR | 7,158 | 0 | 0 | 0 | For |
| John Hancock | 6,998 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. All 52 are in the interactive database (link above).
Meeting held July 9, 2024.
Combines 4 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Description as filed by funds: Election of three Class I Directors: William R. Jellison
ANIKA THERAPEUTICS INC.’s own tally for this item (“Elect Director: William R. Jellison”): 11,092,818 for, 13,085 against, per its Form 8-K filed July 11, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 3,221,348 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 763,999 | 0 | 0 | 0 | For |
| Dimensional | 642,201 | 0 | 0 | 0 | For |
| BlackRock | 548,753 | 0 | 0 | 0 | For |
| Fidelity | 330,778 | 0 | 0 | 0 | For |
| TIAA | 176,547 | 0 | 0 | 0 | For |
| Charles Schwab | 147,890 | 0 | 0 | 0 | For |
| FRANKLIN VALUE INVESTORS TRUST | 129,315 | 0 | 0 | 0 | For |
| SEI | 74,943 | 0 | 0 | 0 | For |
| MFS | 47,551 | 0 | 0 | 0 | For |
| Virtus | 45,579 | 0 | 0 | 0 | For |
| Equitable | 44,143 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 27,284 | 0 | 0 | 0 | For |
| Thrivent | 26,206 | 0 | 0 | 0 | For |
| American Century | 22,730 | 0 | 0 | 0 | For |
| Lincoln Financial | 22,721 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 19,816 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 17,314 | 0 | 0 | 0 | For |
| Goldman Sachs | 11,877 | 0 | 0 | 0 | For |
| Northern Trust | 11,406 | 0 | 0 | 0 | For |
| Voya | 9,353 | 0 | 0 | 0 | For |
| State Street | 8,635 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 7,508 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 7,451 | 0 | 0 | 0 | For |
| AQR | 7,158 | 0 | 0 | 0 | For |
| John Hancock | 6,998 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. All 52 are in the interactive database (link above).
Meeting held July 9, 2024.
Combines 3 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Election of three Class I Directors: Sheryl L. Conley
ANIKA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Sheryl L. Conley”): 10,713,825 for, 415,055 against, per its Form 8-K filed July 11, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 51 asset managers below reported 3,184,031 for, 20,003 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 763,999 | 0 | 0 | 0 | For |
| Dimensional | 642,201 | 0 | 0 | 0 | For |
| BlackRock | 548,753 | 0 | 0 | 0 | For |
| Fidelity | 330,778 | 0 | 0 | 0 | For |
| TIAA | 176,547 | 0 | 0 | 0 | For |
| Charles Schwab | 147,890 | 0 | 0 | 0 | For |
| FRANKLIN VALUE INVESTORS TRUST | 129,315 | 0 | 0 | 0 | For |
| SEI | 74,943 | 0 | 0 | 0 | For |
| MFS | 47,551 | 0 | 0 | 0 | For |
| Virtus | 45,579 | 0 | 0 | 0 | For |
| Equitable | 25,343 | 18,800 | 0 | 0 | Mixed |
| QUANTITATIVE MASTER SERIES LLC | 27,284 | 0 | 0 | 0 | For |
| Thrivent | 26,206 | 0 | 0 | 0 | For |
| American Century | 22,730 | 0 | 0 | 0 | For |
| Lincoln Financial | 22,721 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 19,816 | 0 | 0 | 0 | For |
| Goldman Sachs | 11,877 | 0 | 0 | 0 | For |
| Northern Trust | 11,406 | 0 | 0 | 0 | For |
| Voya | 9,353 | 0 | 0 | 0 | For |
| State Street | 8,634 | 1 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 7,508 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 7,451 | 0 | 0 | 0 | For |
| AQR | 7,158 | 0 | 0 | 0 | For |
| John Hancock | 6,998 | 0 | 0 | 0 | For |
| Legg Mason | 6,675 | 0 | 0 | 0 | For |
Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).
Meeting held June 20, 2025.
76% Approved · of votes cast
Description as filed by funds: APPROVAL OF THE AMENDMENT TO THE ANIKA THERAPEUTICS, INC. 2017 OMNIBUS INCENTIVE PLAN.
ANIKA THERAPEUTICS INC.’s own tally for this item (“4. The Amendment with respect to the 2017 Plan”): 8,297,563 for, 2,608,925 against — passed, per its Form 8-K filed June 24, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “PROPOSAL 4 Stockholders approved the Amendment with respect to the 2017 Plan.”
Support: 76% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of ANIKA THERAPEUTICS INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Amend Omnibus Stock Plan” (2 managers, 24,815 for).
The 52 asset managers below reported 2,064,577 for, 186,508 against, 828 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 765,129 | 0 | 0 | 0 | For |
| BlackRock | 584,229 | 0 | 0 | 0 | For |
| Fidelity | 293,361 | 18,632 | 0 | 0 | Mixed |
| Charles Schwab | 136,617 | 0 | 0 | 0 | For |
| MFS | 0 | 45,449 | 0 | 0 | Against |
| Equitable | 43,528 | 0 | 0 | 0 | For |
| TIAA | 0 | 40,946 | 0 | 0 | Against |
| American Century | 0 | 38,649 | 0 | 0 | Against |
| SEI | 29,387 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 24,937 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 22,650 | 0 | 0 | 0 | For |
| Nationwide | 21,802 | 0 | 0 | 0 | For |
| Goldman Sachs | 20,664 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 5,672 | 13,599 | 0 | 0 | Mixed |
| Thrivent | 15,889 | 0 | 0 | 0 | For |
| Lincoln Financial | 2,986 | 9,395 | 0 | 0 | Mixed |
| State Street | 72 | 10,436 | 0 | 0 | Against |
| Northern Trust | 10,337 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 8,959 | 0 | 0 | 0 | For |
| Global X | 7,891 | 0 | 0 | 0 | For |
| WisdomTree | 7,612 | 0 | 0 | 0 | For |
| John Hancock | 7,193 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,622 | 0 | 0 | 0 | For |
| Pacific Life | 5,917 | 0 | 0 | 0 | For |
| Jackson National | 5,244 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. All 52 are in the interactive database (link above).
Meeting held July 9, 2024.
Combines 6 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: ADVISORY VOTE ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.
ANIKA THERAPEUTICS INC.’s own tally for this item (“3. Stockholders voted, on a non-binding, advisory basis, to approve the compensation paid to the Company's named executive officers as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussi”): 11,020,273 for, 129,717 against, per its Form 8-K filed July 11, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 763,999 | 0 | 0 | 0 | For |
| Dimensional | 642,201 | 0 | 0 | 0 | For |
| BlackRock | 542,699 | 0 | 0 | 0 | For |
| Fidelity | 330,486 | 0 | 0 | 0 | For |
| TIAA | 164,865 | 0 | 0 | 0 | For |
| Charles Schwab | 142,079 | 0 | 0 | 0 | For |
| FRANKLIN VALUE INVESTORS TRUST | 129,315 | 0 | 0 | 0 | For |
| SEI | 71,873 | 0 | 0 | 0 | For |
| MFS | 47,551 | 0 | 0 | 0 | For |
| Virtus | 45,579 | 0 | 0 | 0 | For |
| Equitable | 32,448 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 27,284 | 0 | 0 | 0 | For |
| Thrivent | 26,206 | 0 | 0 | 0 | For |
| American Century | 22,730 | 0 | 0 | 0 | For |
| Lincoln Financial | 22,721 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 19,816 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 17,314 | 0 | 0 | 0 | For |
| Goldman Sachs | 11,877 | 0 | 0 | 0 | For |
| Northern Trust | 11,406 | 0 | 0 | 0 | For |
| Voya | 9,353 | 0 | 0 | 0 | For |
| State Street | 8,635 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 7,508 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 7,451 | 0 | 0 | 0 | For |
| AQR | 7,158 | 0 | 0 | 0 | For |
| John Hancock | 6,998 | 0 | 0 | 0 | For |
Fund voting reports, all 48 managers: 3,179,730 for. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Trigran Investments, Inc. | 1,954,587 | 0 | 0 | 0 | For |
| Caligan Partners LP | 1,360,450 | 0 | 0 | 0 | For |
| BlackRock | 789,764 | 0 | 0 | 0 | For |
| BOOTHBAY FUND MANAGEMENT, LLC | 501,950 | 0 | 0 | 0 | For |
| Renaissance | 474,454 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 336,544 | 0 | 0 | 0 | For |
| State Street | 300,194 | 0 | 0 | 0 | For |
| Nuveen | 176,916 | 0 | 0 | 0 | For |
| DE Shaw | 154,955 | 0 | 0 | 0 | For |
| Charles Schwab | 147,890 | 0 | 0 | 0 | For |
| Meros Investment Management, LP | 143,294 | 0 | 0 | 0 | For |
| Ensign Peak Advisors, Inc | 142,381 | 0 | 0 | 0 | For |
| FRANKLIN MUTUAL ADVISERS LLC | 129,315 | 0 | 0 | 0 | For |
| Northern Trust | 118,969 | 0 | 0 | 0 | For |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 115,297 | 0 | 0 | 0 | For |
| SEGALL BRYANT & HAMILL, LLC | 107,005 | 0 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 104,387 | 0 | 0 | 0 | For |
| GLOBEFLEX CAPITAL L P | 96,435 | 0 | 0 | 0 | For |
| Dimensional | 77,645 | 0 | 0 | 0 | For |
| SEI | 76,206 | 0 | 0 | 0 | For |
| Two Sigma | 71,977 | 0 | 0 | 0 | For |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 71,197 | 0 | 0 | 0 | For |
| AQR | 64,345 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 60,309 | 0 | 0 | 0 | For |
| ENVESTNET ASSET MANAGEMENT INC | 50,680 | 0 | 0 | 0 | For |
Institutional-manager reports, all 123 managers: 8,184,914 for, 22,557 against, 1,448 abstained. Showing the 25 largest; every one is in the interactive database (link above).
Meeting held June 20, 2025.
Combines 7 wordings of this item as funds reported it.
77% Majority: yes · of votes cast
Description as filed by funds: ADVISORY VOTE ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.
ANIKA THERAPEUTICS INC.’s own tally for this item (“3. Stockholders voted, on a non-binding, advisory basis, to approve the compensation paid to the Company's named executive officers as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussi”): 8,374,076 for, 2,529,081 against, per its Form 8-K filed June 24, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 77% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 584,229 | 0 | 0 | 0 | For |
| Vanguard | 315,109 | 0 | 0 | 0 | For |
| Fidelity | 298,838 | 0 | 0 | 0 | For |
| Charles Schwab | 136,617 | 0 | 0 | 0 | For |
| MFS | 45,449 | 0 | 0 | 0 | For |
| Equitable | 43,528 | 0 | 0 | 0 | For |
| American Century | 0 | 38,649 | 0 | 0 | Against |
| TIAA | 30,003 | 0 | 0 | 0 | For |
| SEI | 29,387 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 24,937 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 22,650 | 0 | 0 | 0 | For |
| Nationwide | 21,802 | 0 | 0 | 0 | For |
| Goldman Sachs | 20,664 | 0 | 0 | 0 | For |
| Thrivent | 15,889 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 14,911 | 0 | 0 | 0 | For |
| Lincoln Financial | 9,395 | 2,986 | 0 | 0 | Mixed |
| State Street | 10,508 | 0 | 0 | 0 | For |
| Northern Trust | 10,337 | 0 | 0 | 0 | For |
| GuideStone | 9,904 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 8,959 | 0 | 0 | 0 | For |
| Global X | 7,891 | 0 | 0 | 0 | For |
| WisdomTree | 7,612 | 0 | 0 | 0 | For |
| John Hancock | 5,608 | 1,585 | 0 | 0 | Mixed |
| AIG/SunAmerica | 6,622 | 0 | 0 | 0 | For |
| Pacific Life | 5,917 | 0 | 0 | 0 | For |
Fund voting reports, all 51 managers: 1,722,550 for, 56,951 against, 828 not voted. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Trigran Investments, Inc. | 1,938,455 | 0 | 0 | 0 | For |
| Caligan Partners LP | 0 | 1,434,130 | 0 | 0 | Against |
| BlackRock | 822,646 | 0 | 0 | 0 | For |
| BOOTHBAY FUND MANAGEMENT, LLC | 0 | 529,503 | 0 | 0 | Against |
| Opaleye Management Inc. | 490,888 | 0 | 0 | 0 | For |
| Renaissance | 362,194 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 331,538 | 0 | 0 | 0 | For |
| State Street | 187,732 | 0 | 0 | 0 | For |
| DE Shaw | 148,615 | 0 | 0 | 0 | For |
| Charles Schwab | 136,617 | 0 | 0 | 0 | For |
| Meros Investment Management, LP | 111,056 | 0 | 0 | 0 | For |
| Northern Trust | 101,208 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 94,703 | 0 | 0 | 0 | For |
| GLOBEFLEX CAPITAL L P | 87,600 | 0 | 0 | 0 | For |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 68,062 | 0 | 0 | 0 | For |
| Dimensional | 0 | 64,961 | 0 | 0 | Against |
| ENVESTNET ASSET MANAGEMENT INC | 47,753 | 1,563 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 48,733 | 0 | 0 | 0 | For |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 45,449 | 0 | 0 | 0 | For |
| Wellington | 41,458 | 0 | 0 | 0 | For |
| Nuveen | 41,315 | 0 | 0 | 0 | For |
| American Century | 0 | 38,649 | 0 | 0 | Against |
| Asset Management One Co., Ltd. | 33,780 | 0 | 0 | 0 | For |
| STATE OF WISCONSIN INVESTMENT BOARD | 31,641 | 0 | 0 | 0 | For |
| Citadel | 30,308 | 0 | 0 | 0 | For |
Institutional-manager reports, all 112 managers: 5,572,764 for, 2,078,053 against. Showing the 25 largest; every one is in the interactive database (link above).
Meeting held June 20, 2025.
Combines 2 wordings of this item as funds reported it.
98% Approved · of votes cast
Description as filed by funds: RATIFICATION OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.
ANIKA THERAPEUTICS INC.’s own tally for this item (“2. The appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025”): 12,076,726 for, 248,610 against — passed, per its Form 8-K filed June 24, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “PROPOSAL 2 Stockholders ratified the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 53 asset managers below reported 2,272,905 for, 61 against, 828 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 765,129 | 0 | 0 | 0 | For |
| BlackRock | 584,229 | 0 | 0 | 0 | For |
| Fidelity | 311,993 | 0 | 0 | 0 | For |
| Charles Schwab | 136,617 | 0 | 0 | 0 | For |
| MFS | 45,449 | 0 | 0 | 0 | For |
| Equitable | 43,528 | 0 | 0 | 0 | For |
| TIAA | 40,946 | 0 | 0 | 0 | For |
| American Century | 38,649 | 0 | 0 | 0 | For |
| SEI | 29,387 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 24,937 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 22,650 | 0 | 0 | 0 | For |
| Nationwide | 21,802 | 0 | 0 | 0 | For |
| Goldman Sachs | 20,664 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 19,271 | 0 | 0 | 0 | For |
| Thrivent | 15,889 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 14,911 | 0 | 0 | 0 | For |
| Lincoln Financial | 12,381 | 0 | 0 | 0 | For |
| State Street | 10,507 | 1 | 0 | 0 | For |
| Northern Trust | 10,337 | 0 | 0 | 0 | For |
| GuideStone | 9,904 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 8,959 | 0 | 0 | 0 | For |
| Global X | 7,891 | 0 | 0 | 0 | For |
| WisdomTree | 7,612 | 0 | 0 | 0 | For |
| John Hancock | 7,193 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,622 | 0 | 0 | 0 | For |
Showing the 25 largest of 53 asset managers. All 53 are in the interactive database (link above).
Meeting held July 9, 2024.
Combines 3 wordings of this item as funds reported it.
99.6% Approved · of votes cast
Description as filed by funds: Ratification of appointment of Deloitte & Touche LLP as Anika's independent auditor for 2024; and
ANIKA THERAPEUTICS INC.’s own tally for this item (“2. The appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024”): 12,337,376 for, 43,654 against — passed, per its Form 8-K filed July 11, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “PROPOSAL 2 Stockholders ratified the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 3,221,296 for, 52 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 763,999 | 0 | 0 | 0 | For |
| Dimensional | 642,201 | 0 | 0 | 0 | For |
| BlackRock | 548,753 | 0 | 0 | 0 | For |
| Fidelity | 330,778 | 0 | 0 | 0 | For |
| TIAA | 176,547 | 0 | 0 | 0 | For |
| Charles Schwab | 147,890 | 0 | 0 | 0 | For |
| FRANKLIN VALUE INVESTORS TRUST | 129,315 | 0 | 0 | 0 | For |
| SEI | 74,943 | 0 | 0 | 0 | For |
| MFS | 47,551 | 0 | 0 | 0 | For |
| Virtus | 45,579 | 0 | 0 | 0 | For |
| Equitable | 44,143 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 27,284 | 0 | 0 | 0 | For |
| Thrivent | 26,206 | 0 | 0 | 0 | For |
| American Century | 22,730 | 0 | 0 | 0 | For |
| Lincoln Financial | 22,721 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 19,816 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 17,314 | 0 | 0 | 0 | For |
| Goldman Sachs | 11,877 | 0 | 0 | 0 | For |
| Northern Trust | 11,406 | 0 | 0 | 0 | For |
| Voya | 9,353 | 0 | 0 | 0 | For |
| State Street | 8,635 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 7,508 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 7,451 | 0 | 0 | 0 | For |
| AQR | 7,158 | 0 | 0 | 0 | For |
| John Hancock | 6,998 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. All 52 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 14,839,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 5.16% |
| 2 | BlackRock | 3.94% |
| 3 | Fidelity | 2.10% |
| 4 | Charles Schwab | 0.92% |
| 5 | MFS | 0.31% |
| 6 | Equitable | 0.29% |
| 7 | TIAA | 0.28% |
| 8 | American Century | 0.26% |
| 9 | SEI | 0.20% |
| 10 | Columbia Threadneedle | 0.17% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Trigran Investments, Inc. | 13.17% |
| 2 | Caligan Partners LP | 9.17% |
| 3 | BlackRock | 5.32% |
| 4 | BOOTHBAY FUND MANAGEMENT, LLC | 3.38% |
| 5 | Renaissance | 3.20% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 2.27% |
| 7 | State Street | 2.02% |
| 8 | Nuveen | 1.19% |
| 9 | DE Shaw | 1.04% |
| 10 | Charles Schwab | 1.00% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| BlackRock | 1,519,261 | 10.24% | Form 13F, quarter ended March 31, 2025 |
| Caligan Partners LP | 1,435,130 | 9.67% | Schedule 13D, filed January 27, 2026 |
| BlackRock, Inc. | 963,078 | 6.49% | Schedule 13G, filed April 17, 2025 |
| Vanguard Group | 777,405 | 5.24% | Form 13F, quarter ended March 31, 2025 |
| Dimensional Fund Advisors | 613,972 | 4.14% | Form 13F, quarter ended March 31, 2025 |
| Renaissance Technologies | 528,617 | 3.56% | Form 13F, quarter ended March 31, 2025 |
| State Street | 326,615 | 2.20% | Form 13F, quarter ended March 31, 2025 |
| Trigran Investments, Inc. | 168,400 | 1.13% | Schedule 13G, filed January 8, 2026 |
| D.E. Shaw | 167,760 | 1.13% | Form 13F, quarter ended March 31, 2025 |
| Charles Schwab | 149,935 | 1.01% | Form 13F, quarter ended March 31, 2025 |
Percentages above are of 14,839,000 shares outstanding, as reported by ANIKA THERAPEUTICS INC. on its Form 10-Q dated June 30, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At ANIKA THERAPEUTICS INC.'s 2 shareholder meetings in the 2024-2025 proxy season (held July 9, 2024 and June 20, 2025), 187 asset managers reported votes on at least one of its 11 ballot items in their SEC Form N-PX filings, covering 2,024 separate fund positions. On the most widely held item of the season, voted at the meeting held July 9, 2024 — ADVISORY VOTE ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS. — FOR was 99% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: ANIKA THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on July 11, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ANIKA THERAPEUTICS INC.’s 10-Q dated June 30, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
ANIKA THERAPEUTICS INC. proxy season coverage: 2024-2025 (this page) · 2025-2026.
Proxy Votes Now, “ANIKA THERAPEUTICS (ANIK) 2024-2025 Annual Meetings: Vote Results”, https://proxyvotesnow.com/company/anika-therapeutics-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.